Consensus XP Inc.

Equities

XP

KYG982391099

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-02 pm EDT			5-day change	1st Jan Change
16.7 ^USD	-0.77%		-6.65%	-35.94%

Jun. 29	XP Inc. Announces Pricing of Senior Notes Offering	CI
Jun. 05	Citigroup Adjusts Price Target on XP to $27 From $29, Maintains Buy Rating	MT

Evolution of the average Target Price on XP Inc.

Price target over the last 5 years

History of analyst recommendation changes

bf83c26a232788b.bs8gZaQoO23f-az6S95JnXG4uC-_d95alqHiTxPipyk.NJ90EZJyXhuTzujPerIm5QvAz33TOYc20tDbGlGq320a4g0P4BhIPYWVxw~5a6005884498dcf62b5eef0c64d1f5b6

Analyst Recommendations on XP Inc.

Citigroup Adjusts Price Target on XP to $27 From $29, Maintains Buy Rating	Jun. 05	MT
XP Shares Decline After Goldman Sachs Downgrade	Apr. 30	MT
Goldman Sachs Downgrades XP to Neutral From Buy, Cuts Price Target to $23 From $30	Apr. 30	MT
Morgan Stanley Downgrades XP to Equalweight From Overweight, Adjusts Price Target to $24 From $31	Apr. 23	MT
Citigroup Adjusts Price Target on XP to $29 From $28, Maintains Buy Rating	Mar. 22	MT
UBS Adjusts XP Price Target to $30 From $31, Maintains Buy Rating	Dec. 11	MT
JPMorgan Upgrades XP to Overweight From Neutral, Raises Price Target to $30 From $27	Dec. 05	MT
UBS Trims XP's Price Target to $31 From $33, Keeps Buy Rating	Nov. 06	MT
UBS Raises XP's Price Target to $33 From $28, Keeps Buy Rating	23-09-01	MT
JPMorgan Adjusts Price Target on XP to $27 From $18.50, Maintains Neutral Rating	23-08-23	MT
Citigroup Adjusts XP Price Target to $30 From $20, Maintains Buy Rating	23-08-21	MT
Credit Suisse Upgrades XP to Neutral From Underperform, Adjusts Price Target to $26 From $15	23-07-20	MT
Goldman Sachs Adjusts Price Target on XP to $29 From $22, Maintains Buy Rating	23-07-10	MT
BofA Securities Upgrades XP to Buy From Neutral	23-06-22	MT
UBS Raises XP's Price Target to $28 From $21, Maintains Buy Rating	23-06-20	MT
Bradesco BBI Downgrades XP to Neutral From Outperform, Adjusts Price Target to $17 From $25	23-05-18	MT
Goldman Sachs Adjusts Price Target on XP to $22 From $20, Maintains Buy Rating	23-05-16	MT
UBS Adjusts XP Price Target to $21 From $28, Maintains Buy Rating	23-03-31	MT
Goldman Sachs Cuts XP's Price Target to $20 From $30, Maintains Buy Rating	23-03-02	MT
HSBC Adjusts Price Target on XP to $20 From $26, Maintains Buy Rating	23-02-28	MT
Citigroup Adjusts XP Price Target to $19 From $24, Maintains Buy Rating	23-02-27	MT
Goldman Sachs Adjusts Price Target on XP to $35 From $40, Maintains Buy Rating	22-11-28	MT
UBS Adjusts XP Price Target to $28 From $31, Maintains Buy Rating	22-10-27	MT
Goldman Sachs Raises Price Target on XP to $40 From $46, Keeps Buy Rating	22-08-16	MT
JPMorgan Downgrades XP to Neutral From Overweight; Price Target is $23	22-08-11	MT